High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme

Thomas J. Esparza(National Institute of Mental Health), David L. Brody(Uniformed Services University of the Health Sciences)

Scientific Reports

December 22, 2020

10.1038/s41598-020-79036-0

Cited by 123

Related Papers

Detection of Blast-Related Traumatic Brain Injury in U.S. Military Personnel

|New England Journal of Medicine|2011|596

National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome

|Neurology|2021|322

Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain

|Scientific Reports|2017|165

Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer’s related amyloid-beta pathology

|PLoS ONE|2022|16

Pharmacokinetics of Single Domain Antibodies and Conjugated Nanoparticles Using a Hybrid near Infrared Method

|International Journal of Molecular Sciences|2021|15